
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Efficacy and safety of a biosimilar laronidase versus the reference laronidase in patients with mucopolysaccharidosis type I - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="D2E4B6338AF3B9B305B633002E9A836E.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="scirep">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12365282/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Scientific Reports">
<meta name="citation_title" content="Efficacy and safety of a biosimilar laronidase versus the reference laronidase in patients with mucopolysaccharidosis type I">
<meta name="citation_author" content="Ali Rabbani">
<meta name="citation_author_institution" content="Department of Pediatrics, School of Medicine, Growth and Development Research Center, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran">
<meta name="citation_author" content="Mohammadreza Alaei">
<meta name="citation_author_institution" content="Mofid Children’s Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran">
<meta name="citation_author" content="Samaneh Norouzi Asl">
<meta name="citation_author_institution" content="Pediatrics Endocrinology Department, Mashhad University of Medicine, Mashhad, Iran">
<meta name="citation_author_institution" content="Clinical Research Development Unit of Akbar Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran">
<meta name="citation_author" content="Aria Setoodeh">
<meta name="citation_author_institution" content="Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran">
<meta name="citation_author" content="Marjan Shakiba">
<meta name="citation_author_institution" content="Department of Pediatric Endocrinology and Metabolism, Mofid Children’s Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran">
<meta name="citation_author" content="Shadab Salehpour">
<meta name="citation_author_institution" content="Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran">
<meta name="citation_author" content="Peyman Eshraghi">
<meta name="citation_author_institution" content="Clinical Research Development Unit of Akbar Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran">
<meta name="citation_author_institution" content="Mashhad University of Medicine, Mashhad, Iran">
<meta name="citation_author" content="Omid Salehpour">
<meta name="citation_author_institution" content="Negah Eye Hospital, Tehran, Iran">
<meta name="citation_author" content="Araz Sabzvari">
<meta name="citation_author_institution" content="CinnaGen Medical Biotechnology Research Center, Alborz University of Medical Sciences, Karaj, Iran">
<meta name="citation_author" content="Hamidreza Kafi">
<meta name="citation_author_institution" content="Medical Department, Orchid Pharmed Company, Tehran, Iran">
<meta name="citation_author" content="Ali Jarollahi">
<meta name="citation_author_institution" content="Pars Hospital Laboratory, Tehran, Iran">
<meta name="citation_publication_date" content="2025 Aug 19">
<meta name="citation_volume" content="15">
<meta name="citation_firstpage" content="30427">
<meta name="citation_doi" content="10.1038/s41598-025-16351-4">
<meta name="citation_pmid" content="40830667">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12365282/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12365282/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12365282/pdf/41598_2025_Article_16351.pdf">
<meta name="description" content="This study assessed the efficacy and safety of a biosimilar Laronidase (CinnaGen Company, Iran), compared to the reference Laronidase (Aldurazyme, BioMarin, USA) in maintaining urinary glycosaminoglycan (uGAG) levels in mucopolysaccharidosis type I ...">
<meta name="og:title" content="Efficacy and safety of a biosimilar laronidase versus the reference laronidase in patients with mucopolysaccharidosis type I">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="This study assessed the efficacy and safety of a biosimilar Laronidase (CinnaGen Company, Iran), compared to the reference Laronidase (Aldurazyme, BioMarin, USA) in maintaining urinary glycosaminoglycan (uGAG) levels in mucopolysaccharidosis type I ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12365282/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12365282">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1038/s41598-025-16351-4"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/41598_2025_Article_16351.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12365282%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12365282/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12365282/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12365282/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-scirep.jpg" alt="Scientific Reports logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Scientific Reports" title="Link to Scientific Reports" shape="default" href="http://www.nature.com/srep" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Sci Rep</button></div>. 2025 Aug 19;15:30427. doi: <a href="https://doi.org/10.1038/s41598-025-16351-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1038/s41598-025-16351-4</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Sci%20Rep%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sci%20Rep%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Sci%20Rep%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Sci%20Rep%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Efficacy and safety of a biosimilar laronidase versus the reference laronidase in patients with mucopolysaccharidosis type I</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rabbani%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Ali Rabbani</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Ali Rabbani</span></h3>
<div class="p">
<sup>1</sup>Department of Pediatrics, School of Medicine, Growth and Development Research Center, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rabbani%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Ali Rabbani</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Alaei%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Mohammadreza Alaei</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Mohammadreza Alaei</span></h3>
<div class="p">
<sup>2</sup>Mofid Children’s Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Alaei%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Mohammadreza Alaei</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Asl%20SN%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Samaneh Norouzi Asl</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Samaneh Norouzi Asl</span></h3>
<div class="p">
<sup>3</sup>Pediatrics Endocrinology Department, Mashhad University of Medicine, Mashhad, Iran </div>
<div class="p">
<sup>4</sup>Clinical Research Development Unit of Akbar Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Asl%20SN%22%5BAuthor%5D" class="usa-link"><span class="name western">Samaneh Norouzi Asl</span></a>
</div>
</div>
<sup>3,</sup><sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Setoodeh%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Aria Setoodeh</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Aria Setoodeh</span></h3>
<div class="p">
<sup>5</sup>Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Setoodeh%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Aria Setoodeh</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Shakiba%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Marjan Shakiba</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Marjan Shakiba</span></h3>
<div class="p">
<sup>6</sup>Department of Pediatric Endocrinology and Metabolism, Mofid Children’s Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Shakiba%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Marjan Shakiba</span></a>
</div>
</div>
<sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Salehpour%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Shadab Salehpour</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Shadab Salehpour</span></h3>
<div class="p">
<sup>7</sup>Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Salehpour%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Shadab Salehpour</span></a>
</div>
</div>
<sup>7</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Eshraghi%20P%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Peyman Eshraghi</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Peyman Eshraghi</span></h3>
<div class="p">
<sup>4</sup>Clinical Research Development Unit of Akbar Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran </div>
<div class="p">
<sup>8</sup>Mashhad University of Medicine, Mashhad, Iran </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Eshraghi%20P%22%5BAuthor%5D" class="usa-link"><span class="name western">Peyman Eshraghi</span></a>
</div>
</div>
<sup>4,</sup><sup>8</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Salehpour%20O%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Omid Salehpour</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Omid Salehpour</span></h3>
<div class="p">
<sup>9</sup>Negah Eye Hospital, Tehran, Iran </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Salehpour%20O%22%5BAuthor%5D" class="usa-link"><span class="name western">Omid Salehpour</span></a>
</div>
</div>
<sup>9</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sabzvari%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Araz Sabzvari</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Araz Sabzvari</span></h3>
<div class="p">
<sup>10</sup>CinnaGen Medical Biotechnology Research Center, Alborz University of Medical Sciences, Karaj, Iran </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sabzvari%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Araz Sabzvari</span></a>
</div>
</div>
<sup>10</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kafi%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Hamidreza Kafi</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Hamidreza Kafi</span></h3>
<div class="p">
<sup>11</sup>Medical Department, Orchid Pharmed Company, Tehran, Iran </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kafi%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Hamidreza Kafi</span></a>
</div>
</div>
<sup>11</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jarollahi%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Ali Jarollahi</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Ali Jarollahi</span></h3>
<div class="p">
<sup>12</sup>Pars Hospital Laboratory, Tehran, Iran </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jarollahi%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Ali Jarollahi</span></a>
</div>
</div>
<sup>12</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Department of Pediatrics, School of Medicine, Growth and Development Research Center, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran </div>
<div id="Aff2">
<sup>2</sup>Mofid Children’s Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran </div>
<div id="Aff3">
<sup>3</sup>Pediatrics Endocrinology Department, Mashhad University of Medicine, Mashhad, Iran </div>
<div id="Aff4">
<sup>4</sup>Clinical Research Development Unit of Akbar Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran </div>
<div id="Aff5">
<sup>5</sup>Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran </div>
<div id="Aff6">
<sup>6</sup>Department of Pediatric Endocrinology and Metabolism, Mofid Children’s Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran </div>
<div id="Aff7">
<sup>7</sup>Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran </div>
<div id="Aff8">
<sup>8</sup>Mashhad University of Medicine, Mashhad, Iran </div>
<div id="Aff9">
<sup>9</sup>Negah Eye Hospital, Tehran, Iran </div>
<div id="Aff10">
<sup>10</sup>CinnaGen Medical Biotechnology Research Center, Alborz University of Medical Sciences, Karaj, Iran </div>
<div id="Aff11">
<sup>11</sup>Medical Department, Orchid Pharmed Company, Tehran, Iran </div>
<div id="Aff12">
<sup>12</sup>Pars Hospital Laboratory, Tehran, Iran </div>
<div class="author-notes p"><div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Apr 6; Accepted 2025 Aug 14; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by-nc-nd/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by-nc-nd/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12365282  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40830667/" class="usa-link">40830667</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<p id="Par1">This study assessed the efficacy and safety of a biosimilar Laronidase (CinnaGen Company, Iran), compared to the reference Laronidase (Aldurazyme, BioMarin, USA) in maintaining urinary glycosaminoglycan (uGAG) levels in mucopolysaccharidosis type I (MPS I) patients. In this phase III, open-label, single-sequence, and cross-over study, MPS I patients received Aldurazyme for 12 weeks, followed by Laronidase (CinnaGen) for another 12 weeks. The primary outcome was the assessment of mean uGAG levels at the final visits of each medication administration. The secondary outcomes included the assessment of 6-minute walking test (6MWT), predicted forced vital capacity (FVC), enzyme activity assay, and adverse events (AEs). Twelve patients with mean (standard deviation [SD]) age of 10.25 ± 3.11 years were included in the study. The mean (± SD) uGAG level was 220.47 ± 177.13 CPC unit/g creatinine at the end of Aldurazyme treatment and changed to 270.02 ± 111.55 CPC unit/g creatinine at the end of Laronidase (CinnaGen) treatment, with variable patient responses. The mean 6MWT and predicted FVC improved by almost 30 m and 13%, respectively. Post-infusion enzyme activity levels showed similar patterns between Aldurazyme and Laronidase (CinnaGen), with no detectable activity before the infusion. A total of 30 AEs were reported during the trial. In the first time period (receiving Aldurazyme), AEs were reported for seven patients (58.33%), and in the subsequent time period (receiving Laronidase (CinnaGen)), AEs were reported for six patients (50%). Among all, nasopharyngitis was the most common reported AE. In conclusion, the biosimilar Laronidase was shown to have a comparable efficacy and safety profile compared with the reference Laronidase.</p>
<p>Clinical Trial Registration: Clinicaltrials.gov: <a href="https://clinicaltrials.gov/ct2/show/NCT06406153" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT06406153</a>; First registration: 09/05/2024.</p>
<section id="sec1"><h3 class="pmc_sec_title">Supplementary Information</h3>
<p>The online version contains supplementary material available at 10.1038/s41598-025-16351-4.</p></section><section id="kwd-group1" lang="en" class="kwd-group"><p><strong>Keywords:</strong> Mucopolysaccharidosis, Urinary glycosaminoglycans, Laronidase, Aldurazyme</p></section><section id="kwd-group2" class="kwd-group"><p><strong>Subject terms:</strong> Endocrinology, Drug development, Clinical trial design</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="Par4">Mucopolysaccharidosis type I (MPS I) is a rare genetic disorder characterized by a deficiency of alpha-L-iduronidase (IDUA), a crucial enzyme responsible for the breakdown of glycosaminoglycans (GAGs)<sup><a href="#CR1" class="usa-link" aria-describedby="CR1">1</a></sup>. GAGs are long chains of sugar molecules found throughout the body. When their metabolism is impaired due to insufficient IDUA, they accumulate in various tissues, leading to a spectrum of health issues, including organomegaly, skeletal abnormalities, cardiovascular complications, respiratory issues, and neurological decline<sup><a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>–<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a></sup>. The accumulation of GAGs in cells and tissues leads to their excessive urinary excretion, a hallmark feature of the disease. This characteristic serves as a rapid screening tool to aid in diagnosis<sup><a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>,<a href="#CR5" class="usa-link" aria-describedby="CR5">5</a></sup>. The MPS I spectrum is classified into two broad groups, including attenuated MPS I (Hurler-Scheie and Scheie syndromes) and severe MPS I (Hurler syndrome), with a wide range of phenotypes in between<sup><a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>,<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a></sup>. The estimated prevalence of MPS I ranges from 1 in 100,000 (for severe forms) to 1 in 500,000 (for non-severe forms) live births, with significant variability across different populations<sup><a href="#CR8" class="usa-link" aria-describedby="CR8">8</a></sup>.</p>
<p id="Par5">The accumulation of GAGs, including heparan sulfate and dermatan sulfate, leads to multi-organ failure if left untreated. Early diagnosis and intervention are critical to slowing disease progression and improving patient outcomes<sup><a href="#CR1" class="usa-link" aria-describedby="CR1">1</a></sup>. Aldurazyme (Laronidase), the first FDA-approved enzyme replacement therapy (ERT) for MPS I, has been a cornerstone in managing the disease. Laronidase, a recombinant form of IDUA, works by providing an external source of the deficient enzyme, facilitating the breakdown of accumulated GAGs and alleviating some of the clinical manifestations of MPS I. While ERT does not cure the disease, it has been shown to improve organ function, reduce urinary GAG (uGAG) levels, and enhance quality of life<sup><a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>,<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a></sup>. Although Aldurazyme offers several benefits, its high cost remains a significant challenge. This highlights the need for more affordable alternatives and the development of biosimilars, which can provide lower costs while preserving therapeutic efficacy. A biosimilar is a biological product that closely resembles an authorized reference product in terms of quality, safety, and efficacy. This similarity is established through comprehensive assessments, including analytical and clinical studies. The active substance must have the same amino acid sequence as the reference product, and any minor differences in inactive components should not affect therapeutic performance<sup><a href="#CR11" class="usa-link" aria-describedby="CR11">11</a></sup>.</p>
<p id="Par6">However, in the context of rare diseases such as MPS I, conducting equivalency or non-inferiority studies for biosimilars presents significant challenges. Given the limited patient population, it is often not feasible to conduct adequately powered, randomized controlled trials that directly compare the biosimilar with the reference biologic. Consequently, regulatory agencies typically adopt alternative approaches, including the recruitment of accessible patients to compare efficacy and safety. This paradigm shift recognizes the ethical and logistical challenges of studying rare diseases. It seeks to balance patient access to potentially life-saving therapies with the rigorous evaluation of biosimilar safety and efficacy.</p>
<p id="Par7">A biosimilar version of Laronidase was developed by CinnaGen Company, Iran. Like the reference product (Aldurazyme), Laronidase (CinnaGen) is expressed in Chinese Hamster Ovary (CHO) cell lines, ensuring consistency in post-translational modifications critical to therapeutic activity. A thorough comparability exercise was performed prior to initiating the clinical trial, encompassing analytical characterization, structural integrity, biological activity, glycosylation profiles, impurity profiles, and stability—in addition to manufacturing process consistency and process validation aligned with international standards.</p>
<p id="Par8">The objective of this study was to evaluate the efficacy of this biosimilar Laronidase in maintaining the uGAG levels and clinical efficacy within the ranges provided by Aldurazyme in patients with MPS I, as well as assessing its safety profile.</p></section><section id="Sec2"><h2 class="pmc_sec_title">Methods</h2>
<section id="Sec3"><h3 class="pmc_sec_title">Study design and participants</h3>
<p id="Par9">This phase III, open-label, single-sequence, cross-over study was conducted in four centers in Iran. Patients aged between 5 and 18 years and diagnosed with MPS I were eligible for the study. The exclusion criteria were as follows: prior bone marrow transplantation or being a candidate for receiving haematopoietic stem cell transplantation (HSCT); prior tracheotomy; being naïve to Laronidase; acute hydrocephalus; abnormal renal function determined by measuring serum creatinine and blood urea nitrogen (BUN) levels; any severe organic disease that was not associated with MPS I; known hypersensitivity to Laronidase or components of the Laronidase solution; presence of any medical condition or other circumstances that could significantly interfere with study compliance; pregnancy and lactation; and administration of any investigational drug within 30 days before study enrollment.</p>
<p id="Par10">Written informed consent was obtained from all legal guardians of the patients. The study was approved by the ethics committee of the Tehran University of Medical Sciences (IR.TUMS.TIPS.REC.1401.001), and was registered at Clinicaltrials.gov (<a href="https://clinicaltrials.gov/ct2/show/NCT06406153" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT06406153</a>).</p></section><section id="Sec4"><h3 class="pmc_sec_title">Intervention</h3>
<p id="Par11">The subjects received Aldurazyme for 12 weeks (week 0–11) at a dose of 0.58 mg/kg, followed by Laronidase (CinnaGen) for an additional 12 weeks (week 12–23) at the same dose. The final visit (week 24) was for the patient follow-up. The patients received premedication with antipyretics and/or antihistamines one hour before the infusion started.</p></section><section id="Sec5"><h3 class="pmc_sec_title">Outcomes and assessments</h3>
<p id="Par12">The primary outcome of the study was to compare the mean uGAG levels at weeks 8, 10, and 12 (uGAG<sub>1</sub>; related to Aldurazyme) with the mean uGAG levels at weeks 20, 22, and 24 (uGAG<sub>2</sub>; related to Laronidase (CinnaGen)). For the uGAG level assessment, 50 mL of the patient’s urine samples were collected before the medication infusion, and the cetylpyridinium chloride (CPC) method was performed on the samples. Age-specific uGAG normal levels are shown in Supplementary Table <a href="#MOESM1" class="usa-link">S1</a>.</p>
<p id="Par13">The secondary outcomes were the assessment of changes in 6-minute walking test (6MWT) and predicted forced vital capacity (FVC), comparing the enzyme activity level at the last visit of each period, and the assessment of the adverse events (AEs).</p>
<p id="Par14">For the enzyme activity assay, blood samples were collected from the patients before the infusion, immediately post-infusion, at 30 min, and 90 min after the infusion. Laronidase activity was measured in dried blood spot (DBS) samples using 4-methylumbelliferyl-α-L-iduronide free acid as a synthetic substrate. The blood was extracted from the DBS samples and incubated with the substrate for 20 h at 37 °C. The reaction was then stopped using a glycine carbonate buffer, and fluorescence intensity was measured at excitation and emission wavelengths of 365 nm and 450 nm, respectively. Enzyme activity was quantified using a standard curve generated from dilutions of 4-methylumbelliferone (4MU), the reaction product<sup><a href="#CR12" class="usa-link" aria-describedby="CR12">12</a></sup>.</p></section><section id="Sec6"><h3 class="pmc_sec_title">Safety assessment</h3>
<p id="Par15">Safety assessments were performed during the study, and all AEs were categorized utilizing the Medical Dictionary for Regulatory Activities (MedDRA)<sup><a href="#CR13" class="usa-link" aria-describedby="CR13">13</a></sup> employing both System Organ Class (SOC) and Preferred Term (PT) for classification. The severity of the reported AEs was determined using the Common Terminology Criteria for AEs, version 5.0 (CTCAE v5.0)<sup><a href="#CR14" class="usa-link" aria-describedby="CR14">14</a></sup>. Additionally, serious adverse events (SAEs) were documented according to the (E2B(R2)) guideline<sup><a href="#CR15" class="usa-link" aria-describedby="CR15">15</a></sup>. The causal relationship of AEs was evaluated following the criteria established by the World Health Organization (WHO)<sup><a href="#CR16" class="usa-link" aria-describedby="CR16">16</a></sup>.</p>
<p id="Par16">Considering the study design, all reported AEs were assessed based on the study periods (period 1: week 0–11 receiving Aldurazyme, period 2: week 12–23 receiving Laronidase (CinnaGen)).</p></section><section id="Sec7"><h3 class="pmc_sec_title">Statistical analysis</h3>
<p id="Par17">Due to the rarity and genetic complexity of MPS I, we were able to enroll only 12 patients in this study, which resulted in considerable limitations in statistical power. As a consequence of the small sample size, formal statistical tests, such as hypothesis testing, confidence intervals, and p-values, were not applicable. Therefore, non-inferiority or equivalency testing could not be performed. The main aim of this study was to demonstrate whether the biosimilar Laronidase preserves the clinical effects of Aldurazyme, thereby supporting the concept of comparability in terms of efficacy and safety. In this context, the primary focus was on assessing the clinical impact of the biosimilar treatment, including its ability to provide therapeutic benefits similar to those of the reference product, Aldurazyme.</p>
<p id="Par18">Given the small cohort, statistical methods were not appropriate, thus a descriptive analysis was employed to highlight individual patient trends and observe clinical outcomes. While we acknowledge the significance of statistical rigor in clinical research, the design and conduct of this study were centered on providing clinical evidence that biosimilar Laronidase could serve as a viable alternative to Aldurazyme for MPS I patients, offering comparable therapeutic benefits. All statistical calculations were performed using STATA version 14.0.</p></section></section><section id="Sec8"><h2 class="pmc_sec_title">Results</h2>
<p id="Par19">A total of 12 patients were enrolled in the study, all receiving Aldurazyme (12 weeks) and Laronidase (CinnaGen) (12 weeks). One patient (patient number 11) was expired after week 9 (Fig. <a href="#Fig1" class="usa-link">1</a>). The demographics and baseline characteristics of the participants are shown in Table <a href="#Tab1" class="usa-link">1</a>.</p>
<figure class="fig xbox font-sm" id="Fig1"><h3 class="obj_head">Fig. 1.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12365282_41598_2025_16351_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8e7/12365282/b8f911910280/41598_2025_16351_Fig1_HTML.jpg" loading="lazy" id="d33e443" height="649" width="708" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>CONSORT flow diagram of the study.</p></figcaption></figure><section class="tw xbox font-sm" id="Tab1"><h3 class="obj_head">Table 1.</h3>
<div class="caption p"><p>Demographics and baseline characteristics of the participants.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Characteristics</th>
<th align="left" colspan="1" rowspan="1">All patients (<em>n</em> = 12)</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Gender (Female), n (%)</td>
<td align="left" colspan="1" rowspan="1">5 (41.67)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Age (years), mean ± SD</td>
<td align="left" colspan="1" rowspan="1">10.25 ± 3.11</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<p>Body-mass index</p>
<p>(kg/m<sup>2</sup>),</p>
<p>mean ± SD</p>
</td>
<td align="left" colspan="1" rowspan="1">17.49 ± 4.15</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Height (cm), mean ± SD</td>
<td align="left" colspan="1" rowspan="1">121.13 ± 21.34</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Weight (kg), mean ± SD</td>
<td align="left" colspan="1" rowspan="1">27.79 ± 17.40</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">LVEF (%), mean ± SD</td>
<td align="left" colspan="1" rowspan="1">59.63 ± 6.20</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<p>uGAG (CPC unit/g</p>
<p>creatinine), mean ± SD</p>
</td>
<td align="left" colspan="1" rowspan="1">187.90 ± 129.46</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<p>FVC (% of predicted</p>
<p>normal), mean ± SD</p>
</td>
<td align="left" colspan="1" rowspan="1">54.75 ± 16.55</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">6MWT (m)</td>
<td align="left" colspan="1" rowspan="1">328.88 ± 118.04</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">BCVA</td>
<td align="left" colspan="1" rowspan="1">125.45 ± 226.16</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p31"><p>6MWT: 6-minute walking test; BCVA: best corrected visual acuity; FVC: forced vital capacity; LVEF: left ventricular ejection fraction; uGAG: urinary glycosaminoglycans.</p></div></div></section><section id="Sec9"><h3 class="pmc_sec_title">uGAG levels changes</h3>
<p id="Par22">The mean (± standard deviation [SD]) uGAG levels changed from 220.47 ± 177.13 CPC unit/g creatinine (uGAG<sub>1</sub>) at the end of Aldurazyme treatment to 270.02 ± 111.55 CPC unit/g creatinine (uGAG<sub>2</sub>) at the end of Laronidase (CinnaGen) treatment. Figure <a href="#Fig2" class="usa-link">2</a> demonstrates the trend of uGAG levels from the end of Aldurazyme treatment period to the end of Laronidase (CinnaGen) treatment period.</p>
<figure class="fig xbox font-sm" id="Fig2"><h4 class="obj_head">Fig. 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12365282_41598_2025_16351_Fig2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8e7/12365282/39ca4d87001d/41598_2025_16351_Fig2_HTML.jpg" loading="lazy" id="d33e545" height="402" width="750" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>The urinary glycosaminoglycan (uGAG) levels per patient.</p></figcaption></figure></section><section id="Sec10"><h3 class="pmc_sec_title">6MWT and predicted FVC changes</h3>
<p id="Par24">The mean (± SD) 6MWT results increased from 328.22 ± 98.69 m at week 12 (related to Aldurazyme) to 360.20 ± 98.11 m at week 24 (related to Laronidase (CinnaGen)). In addition, the mean (± SD) predicted FVC results increased from 57.50 ± 16.53% at week 12 (related to Aldurazyme) to 70.56 ± 35.01% at week 24 (related to Laronidase (CinnaGen)). The individual data of changes in 6MWT and predicted FVC during the study are presented in Table <a href="#Tab2" class="usa-link">2</a>.</p>
<section class="tw xbox font-sm" id="Tab2"><h4 class="obj_head">Table 2.</h4>
<div class="caption p"><p>The 6-minute walking test and predicted forced vital capacity results per patient.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Patient number</th>
<th align="left" colspan="1" rowspan="1">1</th>
<th align="left" colspan="1" rowspan="1">2</th>
<th align="left" colspan="1" rowspan="1">3</th>
<th align="left" colspan="1" rowspan="1">4</th>
<th align="left" colspan="1" rowspan="1">5</th>
<th align="left" colspan="1" rowspan="1">6</th>
<th align="left" colspan="1" rowspan="1">7</th>
<th align="left" colspan="1" rowspan="1">8</th>
<th align="left" colspan="1" rowspan="1">9</th>
<th align="left" colspan="1" rowspan="1">10</th>
<th align="left" colspan="1" rowspan="1">11</th>
<th align="left" colspan="1" rowspan="1">12</th>
</tr></thead>
<tbody>
<tr><td align="left" colspan="13" rowspan="1">6MWT (m)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<p> Aldurazyme Diff.<sup>*</sup></p>
<p>(week 12 –</p>
<p>week 0)</p>
</td>
<td align="left" colspan="1" rowspan="1">-45</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="left" colspan="1" rowspan="1">-35.5</td>
<td align="left" colspan="1" rowspan="1">140.5</td>
<td align="left" colspan="1" rowspan="1">-90</td>
<td align="left" colspan="1" rowspan="1">25.5</td>
<td align="left" colspan="1" rowspan="1">
<strong>Missing</strong>
</td>
<td align="left" colspan="1" rowspan="1">-49</td>
<td align="left" colspan="1" rowspan="1">-52.2</td>
<td align="left" colspan="1" rowspan="1">93.01</td>
<td align="left" colspan="1" rowspan="1">
<strong>Missing</strong>
</td>
<td align="left" colspan="1" rowspan="1">46.18</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<p> Laronidase</p>
<p>(CinnaGen)</p>
<p>Diff. (week</p>
<p>24 – week 12)</p>
</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="left" colspan="1" rowspan="1">-35</td>
<td align="left" colspan="1" rowspan="1">22.5</td>
<td align="left" colspan="1" rowspan="1">-22.5</td>
<td align="left" colspan="1" rowspan="1">191</td>
<td align="left" colspan="1" rowspan="1">-19.5</td>
<td align="left" colspan="1" rowspan="1">
<strong>Missing</strong>
</td>
<td align="left" colspan="1" rowspan="1">94</td>
<td align="left" colspan="1" rowspan="1">10.8</td>
<td align="left" colspan="1" rowspan="1">-27.76</td>
<td align="left" colspan="1" rowspan="1">
<strong>Missing</strong>
</td>
<td align="left" colspan="1" rowspan="1">-87.00</td>
</tr>
<tr><td align="left" colspan="13" rowspan="1">FVC (% of predicted normal)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<p> Aldurazyme</p>
<p>Diff. (week</p>
<p>12 – week 0)</p>
</td>
<td align="left" colspan="1" rowspan="1">5</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="left" colspan="1" rowspan="1">9</td>
<td align="left" colspan="1" rowspan="1">14</td>
<td align="left" colspan="1" rowspan="1">-2</td>
<td align="left" colspan="1" rowspan="1">-5</td>
<td align="left" colspan="1" rowspan="1">3</td>
<td align="left" colspan="1" rowspan="1">
<strong>Missing</strong>
</td>
<td align="left" colspan="1" rowspan="1">-25</td>
<td align="left" colspan="1" rowspan="1">10</td>
<td align="left" colspan="1" rowspan="1">
<strong>Missing</strong>
</td>
<td align="left" colspan="1" rowspan="1">-7</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<p> Laronidase</p>
<p> (CinnaGen)</p>
<p>Diff. (week</p>
<p>24 –</p>
<p>week 12)</p>
</td>
<td align="left" colspan="1" rowspan="1">-6</td>
<td align="left" colspan="1" rowspan="1">21</td>
<td align="left" colspan="1" rowspan="1">18</td>
<td align="left" colspan="1" rowspan="1">9</td>
<td align="left" colspan="1" rowspan="1">63</td>
<td align="left" colspan="1" rowspan="1">-28</td>
<td align="left" colspan="1" rowspan="1">
<strong>Missing</strong>
</td>
<td align="left" colspan="1" rowspan="1">
<strong>Missing</strong>
</td>
<td align="left" colspan="1" rowspan="1">4</td>
<td align="left" colspan="1" rowspan="1">11</td>
<td align="left" colspan="1" rowspan="1">
<strong>Missing</strong>
</td>
<td align="left" colspan="1" rowspan="1">18</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p53">
<p>6MWT: 6-minute walking test; FVC: forced vital capacity.</p>
<p>* Diff.: The difference between two times (last time – first time).</p>
</div></div></section></section><section id="Sec11"><h3 class="pmc_sec_title">Enzyme activity assay</h3>
<p id="Par26">The enzyme activity assay was conducted at the final visits of each medication administration (weeks 11 and 23) at four timepoints. Prior to infusion, the enzyme activity was undetectable in all individuals (&lt; 0.1 µmol/h/L of blood). Following Aldurazyme infusion, mean (± SD) enzyme activity levels (µmol/h/L of blood) were 36.06 ± 14.06, 17.49 ± 16.00, and 14.08 ± 19.04, immediately, at 30 min, and 90 min post infusion, respectively. It was also 33.27 ± 16.00, 18.35 ± 12.55, and 8.75 ± 10.96 at the same respective timepoints after Laronidase (CinnaGen) infusion. The individual enzyme activity data are presented in Table <a href="#Tab3" class="usa-link">3</a>.</p>
<section class="tw xbox font-sm" id="Tab3"><h4 class="obj_head">Table 3.</h4>
<div class="caption p"><p>Enzyme activity levels per patient.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" rowspan="2" colspan="1">Patient<br>number</th>
<th align="left" rowspan="2" colspan="1">Week</th>
<th align="left" colspan="4" rowspan="1">Enzyme activity assay (µmol/h/L of blood)</th>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1">Before<br>infusion</th>
<th align="left" colspan="1" rowspan="1">Immediately<br>post-infusion</th>
<th align="left" colspan="1" rowspan="1">30 min after<br>infusion</th>
<th align="left" colspan="1" rowspan="1">90 min after<br>infusion</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="2" colspan="1">1</td>
<td align="left" colspan="1" rowspan="1">11</td>
<td align="left" colspan="1" rowspan="1">&lt;0.1</td>
<td align="left" colspan="1" rowspan="1">40.3</td>
<td align="left" colspan="1" rowspan="1">25.7</td>
<td align="left" colspan="1" rowspan="1">2.13</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">23</td>
<td align="left" colspan="1" rowspan="1">&lt;0.1</td>
<td align="left" colspan="1" rowspan="1">43.5</td>
<td align="left" colspan="1" rowspan="1">15.3</td>
<td align="left" colspan="1" rowspan="1">3.32</td>
</tr>
<tr>
<td align="left" rowspan="2" colspan="1">2</td>
<td align="left" colspan="1" rowspan="1">11</td>
<td align="left" colspan="1" rowspan="1">&lt;0.1</td>
<td align="left" colspan="1" rowspan="1">30.8</td>
<td align="left" colspan="1" rowspan="1">1.49</td>
<td align="left" colspan="1" rowspan="1">&lt;0.1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">23</td>
<td align="left" colspan="1" rowspan="1">&lt;0.1</td>
<td align="left" colspan="1" rowspan="1">22.8</td>
<td align="left" colspan="1" rowspan="1">3.56</td>
<td align="left" colspan="1" rowspan="1">2.49</td>
</tr>
<tr>
<td align="left" rowspan="2" colspan="1">3</td>
<td align="left" colspan="1" rowspan="1">11</td>
<td align="left" colspan="1" rowspan="1">&lt;0.1</td>
<td align="left" colspan="1" rowspan="1">8.13</td>
<td align="left" colspan="1" rowspan="1">6.6</td>
<td align="left" colspan="1" rowspan="1">&lt;0.1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">23</td>
<td align="left" colspan="1" rowspan="1">Missing</td>
<td align="left" colspan="1" rowspan="1">19.1</td>
<td align="left" colspan="1" rowspan="1">6.62</td>
<td align="left" colspan="1" rowspan="1">&lt;0.1</td>
</tr>
<tr>
<td align="left" rowspan="2" colspan="1">4</td>
<td align="left" colspan="1" rowspan="1">11</td>
<td align="left" colspan="1" rowspan="1">&lt;0.1</td>
<td align="left" colspan="1" rowspan="1">27.5</td>
<td align="left" colspan="1" rowspan="1">3.48</td>
<td align="left" colspan="1" rowspan="1">&lt;0.1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">23</td>
<td align="left" colspan="1" rowspan="1">&lt;0.1</td>
<td align="left" colspan="1" rowspan="1">39.1</td>
<td align="left" colspan="1" rowspan="1">23.2</td>
<td align="left" colspan="1" rowspan="1">2.71</td>
</tr>
<tr>
<td align="left" rowspan="2" colspan="1">5</td>
<td align="left" colspan="1" rowspan="1">11</td>
<td align="left" colspan="1" rowspan="1">&lt;0.1</td>
<td align="left" colspan="1" rowspan="1">44.3</td>
<td align="left" colspan="1" rowspan="1">31.1</td>
<td align="left" colspan="1" rowspan="1">12.0</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">23</td>
<td align="left" colspan="1" rowspan="1">&lt;0.1</td>
<td align="left" colspan="1" rowspan="1">31.0</td>
<td align="left" colspan="1" rowspan="1">21.9</td>
<td align="left" colspan="1" rowspan="1">11.2</td>
</tr>
<tr>
<td align="left" rowspan="2" colspan="1">6</td>
<td align="left" colspan="1" rowspan="1">11</td>
<td align="left" colspan="1" rowspan="1">&lt;0.1</td>
<td align="left" colspan="1" rowspan="1">28.5</td>
<td align="left" colspan="1" rowspan="1">9.56</td>
<td align="left" colspan="1" rowspan="1">0.56</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">23</td>
<td align="left" colspan="1" rowspan="1">&lt;0.1</td>
<td align="left" colspan="1" rowspan="1">54.4</td>
<td align="left" colspan="1" rowspan="1">19.2</td>
<td align="left" colspan="1" rowspan="1">6.96</td>
</tr>
<tr>
<td align="left" rowspan="2" colspan="1">7</td>
<td align="left" colspan="1" rowspan="1">11</td>
<td align="left" colspan="1" rowspan="1">&lt;0.1</td>
<td align="left" colspan="1" rowspan="1">54.6</td>
<td align="left" colspan="1" rowspan="1">14.5</td>
<td align="left" colspan="1" rowspan="1">&lt;0.1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">23</td>
<td align="left" colspan="1" rowspan="1">Missing</td>
<td align="left" colspan="1" rowspan="1">Missing</td>
<td align="left" colspan="1" rowspan="1">Missing</td>
<td align="left" colspan="1" rowspan="1">Missing</td>
</tr>
<tr>
<td align="left" rowspan="2" colspan="1">8</td>
<td align="left" colspan="1" rowspan="1">11</td>
<td align="left" colspan="1" rowspan="1">Missing</td>
<td align="left" colspan="1" rowspan="1">39.8</td>
<td align="left" colspan="1" rowspan="1">&lt;0.1</td>
<td align="left" colspan="1" rowspan="1">&lt;0.1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">23</td>
<td align="left" colspan="1" rowspan="1">Missing</td>
<td align="left" colspan="1" rowspan="1">Missing</td>
<td align="left" colspan="1" rowspan="1">Missing</td>
<td align="left" colspan="1" rowspan="1">Missing</td>
</tr>
<tr>
<td align="left" rowspan="2" colspan="1">9</td>
<td align="left" colspan="1" rowspan="1">11</td>
<td align="left" colspan="1" rowspan="1">&lt;0.1</td>
<td align="left" colspan="1" rowspan="1">&lt;0.1</td>
<td align="left" colspan="1" rowspan="1">&lt;0.1</td>
<td align="left" colspan="1" rowspan="1">&lt;0.1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">23</td>
<td align="left" colspan="1" rowspan="1">&lt;0.1</td>
<td align="left" colspan="1" rowspan="1">8.40</td>
<td align="left" colspan="1" rowspan="1">&lt;0.1</td>
<td align="left" colspan="1" rowspan="1">&lt;0.1</td>
</tr>
<tr>
<td align="left" rowspan="2" colspan="1">10</td>
<td align="left" colspan="1" rowspan="1">11</td>
<td align="left" colspan="1" rowspan="1">&lt;0.1</td>
<td align="left" colspan="1" rowspan="1">50.1</td>
<td align="left" colspan="1" rowspan="1">47.4</td>
<td align="left" colspan="1" rowspan="1">41.6</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">23</td>
<td align="left" colspan="1" rowspan="1">&lt;0.1</td>
<td align="left" colspan="1" rowspan="1">55.0</td>
<td align="left" colspan="1" rowspan="1">44.1</td>
<td align="left" colspan="1" rowspan="1">32.4</td>
</tr>
<tr>
<td align="left" rowspan="2" colspan="1">12</td>
<td align="left" colspan="1" rowspan="1">11</td>
<td align="left" colspan="1" rowspan="1">Missing</td>
<td align="left" colspan="1" rowspan="1">Missing</td>
<td align="left" colspan="1" rowspan="1">Missing</td>
<td align="left" colspan="1" rowspan="1">Missing</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">23</td>
<td align="left" colspan="1" rowspan="1">&lt;0.1</td>
<td align="left" colspan="1" rowspan="1">25.7</td>
<td align="left" colspan="1" rowspan="1">12.6</td>
<td align="left" colspan="1" rowspan="1">2.05</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="Sec12"><h3 class="pmc_sec_title">Safety results</h3>
<p id="Par28">During the two study periods, a total of 30 AEs were reported. Table <a href="#Tab4" class="usa-link">4</a> demonstrates a comprehensive record of all AEs during the 24 weeks for each patient. Notably, no AE was reported during the 24th week. Most of the AEs were assessed as grade 1 or 2 and non-serious. Furthermore, they were mostly attributed to the underlying disease rather than treatment. According to the findings, six and four patients experienced at least one AE at periods 1 and 2, respectively.</p>
<section class="tw xbox font-sm" id="Tab4"><h4 class="obj_head">Table 4.</h4>
<div class="caption p"><p>Adverse events reported per patient during the study.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Patient number</th>
<th align="left" colspan="1" rowspan="1">Period</th>
<th align="left" colspan="1" rowspan="1">Week</th>
<th align="left" colspan="1" rowspan="1">System Organ<br>Class</th>
<th align="left" colspan="1" rowspan="1">Preferred Term</th>
<th align="left" colspan="1" rowspan="1">Intensity</th>
<th align="left" colspan="1" rowspan="1">Causality</th>
<th align="left" colspan="1" rowspan="1">Seriousness</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">1</td>
<td align="left" colspan="1" rowspan="1">Aldurazyme</td>
<td align="left" colspan="1" rowspan="1">Week 4</td>
<td align="left" colspan="1" rowspan="1">
<p>Infections and</p>
<p>infestations</p>
</td>
<td align="left" colspan="1" rowspan="1">Nasopharyngitis</td>
<td align="left" colspan="1" rowspan="1">Grade 2</td>
<td align="left" colspan="1" rowspan="1">Unlikely</td>
<td align="left" colspan="1" rowspan="1">
<p>Non-</p>
<p>serious</p>
</td>
</tr>
<tr>
<td align="left" rowspan="2" colspan="1">2</td>
<td align="left" rowspan="2" colspan="1">
<p>Laronidase</p>
<p>(CinnaGen)</p>
</td>
<td align="left" colspan="1" rowspan="1">Week 13</td>
<td align="left" colspan="1" rowspan="1">
<p>General disorders</p>
<p>and administration</p>
<p>site conditions</p>
</td>
<td align="left" colspan="1" rowspan="1">Infusion related reaction</td>
<td align="left" colspan="1" rowspan="1">Grade 1</td>
<td align="left" colspan="1" rowspan="1">Probable/Likely</td>
<td align="left" colspan="1" rowspan="1">
<p>Non-</p>
<p>serious</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Week 14</td>
<td align="left" colspan="1" rowspan="1">
<p>General disorders</p>
<p>and administration</p>
<p>site conditions</p>
</td>
<td align="left" colspan="1" rowspan="1">Infusion related reaction</td>
<td align="left" colspan="1" rowspan="1">Grade 1</td>
<td align="left" colspan="1" rowspan="1">Probable/Likely</td>
<td align="left" colspan="1" rowspan="1">
<p>Non-</p>
<p>serious</p>
</td>
</tr>
<tr>
<td align="left" rowspan="3" colspan="1">3</td>
<td align="left" colspan="1" rowspan="1">Aldurazyme</td>
<td align="left" colspan="1" rowspan="1">Week 5</td>
<td align="left" colspan="1" rowspan="1">
<p>Infections and</p>
<p>infestations</p>
</td>
<td align="left" colspan="1" rowspan="1">Nasopharyngitis</td>
<td align="left" colspan="1" rowspan="1">Grade 2</td>
<td align="left" colspan="1" rowspan="1">Unlikely</td>
<td align="left" colspan="1" rowspan="1">
<p>Non-</p>
<p>serious</p>
</td>
</tr>
<tr>
<td align="left" rowspan="2" colspan="1">
<p>Laronidase</p>
<p>(CinnaGen)</p>
</td>
<td align="left" colspan="1" rowspan="1">Week 14</td>
<td align="left" colspan="1" rowspan="1">
<p>Musculoskeletal and</p>
<p>connective tissue</p>
<p>disorders</p>
</td>
<td align="left" colspan="1" rowspan="1">Pain in extremity</td>
<td align="left" colspan="1" rowspan="1">Grade 1</td>
<td align="left" colspan="1" rowspan="1">Unlikely</td>
<td align="left" colspan="1" rowspan="1">
<p>Non-</p>
<p>serious</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Week 15</td>
<td align="left" colspan="1" rowspan="1">
<p>Infections and</p>
<p>infestations</p>
</td>
<td align="left" colspan="1" rowspan="1">Nasopharyngitis</td>
<td align="left" colspan="1" rowspan="1">Grade 2</td>
<td align="left" colspan="1" rowspan="1">Unlikely</td>
<td align="left" colspan="1" rowspan="1">
<p>Non-</p>
<p>serious</p>
</td>
</tr>
<tr>
<td align="left" rowspan="6" colspan="1">4</td>
<td align="left" colspan="1" rowspan="1">Aldurazyme</td>
<td align="left" colspan="1" rowspan="1">Week 2</td>
<td align="left" colspan="1" rowspan="1">
<p>Infections and</p>
<p>infestations</p>
</td>
<td align="left" colspan="1" rowspan="1">Nasopharyngitis</td>
<td align="left" colspan="1" rowspan="1">Grade 2</td>
<td align="left" colspan="1" rowspan="1">Unlikely</td>
<td align="left" colspan="1" rowspan="1">
<p>Non-</p>
<p>serious</p>
</td>
</tr>
<tr>
<td align="left" rowspan="5" colspan="1">
<p>Laronidase</p>
<p>(CinnaGen)</p>
</td>
<td align="left" colspan="1" rowspan="1">Week 12</td>
<td align="left" colspan="1" rowspan="1">
<p>General disorders</p>
<p>and administration</p>
<p>site conditions</p>
</td>
<td align="left" colspan="1" rowspan="1">Infusion related reaction</td>
<td align="left" colspan="1" rowspan="1">Grade 1</td>
<td align="left" colspan="1" rowspan="1">Probable/Likely</td>
<td align="left" colspan="1" rowspan="1">
<p>Non-</p>
<p>serious</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Week 13</td>
<td align="left" colspan="1" rowspan="1">
<p>General disorders</p>
<p>and administration</p>
<p>site conditions</p>
</td>
<td align="left" colspan="1" rowspan="1">Infusion related reaction</td>
<td align="left" colspan="1" rowspan="1">Grade 1</td>
<td align="left" colspan="1" rowspan="1">Probable/Likely</td>
<td align="left" colspan="1" rowspan="1">
<p>Non-</p>
<p>serious</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Week 19</td>
<td align="left" colspan="1" rowspan="1">
<p>Infections and</p>
<p>infestations</p>
</td>
<td align="left" colspan="1" rowspan="1">Nasopharyngitis</td>
<td align="left" colspan="1" rowspan="1">Grade 2</td>
<td align="left" colspan="1" rowspan="1">Unlikely</td>
<td align="left" colspan="1" rowspan="1">
<p>Non-</p>
<p>serious</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Week 23</td>
<td align="left" colspan="1" rowspan="1">
<p>Gastrointestinal</p>
<p>disorders</p>
</td>
<td align="left" colspan="1" rowspan="1">Abdominal pain</td>
<td align="left" colspan="1" rowspan="1">Grade 1</td>
<td align="left" colspan="1" rowspan="1">Possible</td>
<td align="left" colspan="1" rowspan="1">
<p>Non-</p>
<p>serious</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Week 23</td>
<td align="left" colspan="1" rowspan="1">
<p>Renal and urinary</p>
<p>disorders</p>
</td>
<td align="left" colspan="1" rowspan="1">Pollakiuria</td>
<td align="left" colspan="1" rowspan="1">Grade 1</td>
<td align="left" colspan="1" rowspan="1">Unlikely</td>
<td align="left" colspan="1" rowspan="1">
<p>Non-</p>
<p>serious</p>
</td>
</tr>
<tr>
<td align="left" rowspan="2" colspan="1">6</td>
<td align="left" colspan="1" rowspan="1">Aldurazyme</td>
<td align="left" colspan="1" rowspan="1">Week 2</td>
<td align="left" colspan="1" rowspan="1">
<p>Injury, poisoning and</p>
<p>procedural</p>
<p>complications</p>
</td>
<td align="left" colspan="1" rowspan="1">Contusion</td>
<td align="left" colspan="1" rowspan="1">Grade 1</td>
<td align="left" colspan="1" rowspan="1">Unrelated</td>
<td align="left" colspan="1" rowspan="1">
<p>Non-</p>
<p>serious</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<p>Laronidase</p>
<p>(CinnaGen)</p>
</td>
<td align="left" colspan="1" rowspan="1">Week 13</td>
<td align="left" colspan="1" rowspan="1">
<p>Infections and</p>
<p>infestations</p>
</td>
<td align="left" colspan="1" rowspan="1">Nasopharyngitis</td>
<td align="left" colspan="1" rowspan="1">Grade 1</td>
<td align="left" colspan="1" rowspan="1">Unlikely</td>
<td align="left" colspan="1" rowspan="1">
<p>Non-</p>
<p>serious</p>
</td>
</tr>
<tr>
<td align="left" rowspan="8" colspan="1">8</td>
<td align="left" rowspan="4" colspan="1">Aldurazyme</td>
<td align="left" colspan="1" rowspan="1">Week 6</td>
<td align="left" colspan="1" rowspan="1">
<p>Infections and</p>
<p>infestations</p>
</td>
<td align="left" colspan="1" rowspan="1">Nasopharyngitis</td>
<td align="left" colspan="1" rowspan="1">Grade 2</td>
<td align="left" colspan="1" rowspan="1">Unlikely</td>
<td align="left" colspan="1" rowspan="1">
<p>Non-</p>
<p>serious</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Week 11</td>
<td align="left" colspan="1" rowspan="1">
<p>Nervous system</p>
<p>disorders</p>
</td>
<td align="left" colspan="1" rowspan="1">Paraesthesia</td>
<td align="left" colspan="1" rowspan="1">Grade 1</td>
<td align="left" colspan="1" rowspan="1">Unlikely</td>
<td align="left" colspan="1" rowspan="1">
<p>Non-</p>
<p>serious</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Week 11</td>
<td align="left" colspan="1" rowspan="1">
<p>Respiratory, thoracic</p>
<p>and mediastinal</p>
<p>disorders</p>
</td>
<td align="left" colspan="1" rowspan="1">Cough</td>
<td align="left" colspan="1" rowspan="1">Grade 2</td>
<td align="left" colspan="1" rowspan="1">Unlikely</td>
<td align="left" colspan="1" rowspan="1">
<p>Non-</p>
<p>serious</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Week 11</td>
<td align="left" colspan="1" rowspan="1">
<p>General disorders</p>
<p>and administration</p>
<p>site conditions</p>
</td>
<td align="left" colspan="1" rowspan="1">Infusion related reaction</td>
<td align="left" colspan="1" rowspan="1">Grade 1</td>
<td align="left" colspan="1" rowspan="1">Probable/Likely</td>
<td align="left" colspan="1" rowspan="1">
<p>Non-</p>
<p>serious</p>
</td>
</tr>
<tr>
<td align="left" rowspan="4" colspan="1">
<p>Laronidase</p>
<p>(CinnaGen)</p>
</td>
<td align="left" colspan="1" rowspan="1">Week 13</td>
<td align="left" colspan="1" rowspan="1">
<p>Respiratory, thoracic</p>
<p>and mediastinal</p>
<p>disorders</p>
</td>
<td align="left" colspan="1" rowspan="1">Foreign body aspiration</td>
<td align="left" colspan="1" rowspan="1">Grade 3</td>
<td align="left" colspan="1" rowspan="1">Unrelated</td>
<td align="left" colspan="1" rowspan="1">
<p>Requires in-patient</p>
<p>hospitalization or</p>
<p>prolongation of</p>
<p>existing</p>
<p>hospitalization</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Week 13</td>
<td align="left" colspan="1" rowspan="1">
<p>Infections and</p>
<p>infestations</p>
</td>
<td align="left" colspan="1" rowspan="1">Sinusitis</td>
<td align="left" colspan="1" rowspan="1">Grade 3</td>
<td align="left" colspan="1" rowspan="1">Unlikely</td>
<td align="left" colspan="1" rowspan="1">
<p>Requires in-patient</p>
<p>hospitalization or</p>
<p>prolongation of</p>
<p>existing</p>
<p>hospitalization</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Week 18</td>
<td align="left" colspan="1" rowspan="1">
<p>Infections and</p>
<p>infestations</p>
</td>
<td align="left" colspan="1" rowspan="1">Nasopharyngitis</td>
<td align="left" colspan="1" rowspan="1">Grade 2</td>
<td align="left" colspan="1" rowspan="1">Unlikely</td>
<td align="left" colspan="1" rowspan="1">
<p>Non-</p>
<p>serious</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Week 23</td>
<td align="left" colspan="1" rowspan="1">
<p>Nervous system</p>
<p>disorders</p>
</td>
<td align="left" colspan="1" rowspan="1">Nystagmus</td>
<td align="left" colspan="1" rowspan="1">Grade 2</td>
<td align="left" colspan="1" rowspan="1">Unrelated</td>
<td align="left" colspan="1" rowspan="1">
<p>Non-</p>
<p>serious</p>
</td>
</tr>
<tr>
<td align="left" rowspan="2" colspan="1">9</td>
<td align="left" rowspan="2" colspan="1">
<p>Laronidase</p>
<p>(CinnaGen)</p>
</td>
<td align="left" colspan="1" rowspan="1">Week 18</td>
<td align="left" colspan="1" rowspan="1">
<p>Gastrointestinal</p>
<p>disorders</p>
</td>
<td align="left" colspan="1" rowspan="1">Diarrhoea</td>
<td align="left" colspan="1" rowspan="1">Grade 1</td>
<td align="left" colspan="1" rowspan="1">Possible</td>
<td align="left" colspan="1" rowspan="1">
<p>Non-</p>
<p>serious</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Week 18</td>
<td align="left" colspan="1" rowspan="1">
<p>Respiratory, thoracic</p>
<p>and mediastinal</p>
<p>disorders</p>
</td>
<td align="left" colspan="1" rowspan="1">Cough</td>
<td align="left" colspan="1" rowspan="1">Grade 1</td>
<td align="left" colspan="1" rowspan="1">Possible</td>
<td align="left" colspan="1" rowspan="1">
<p>Non-</p>
<p>serious</p>
</td>
</tr>
<tr>
<td align="left" rowspan="5" colspan="1">11</td>
<td align="left" rowspan="5" colspan="1">Aldurazyme</td>
<td align="left" colspan="1" rowspan="1">Week 1</td>
<td align="left" colspan="1" rowspan="1">
<p>Respiratory, thoracic</p>
<p>and mediastinal</p>
<p>disorders</p>
</td>
<td align="left" colspan="1" rowspan="1">Respiratory disorder</td>
<td align="left" colspan="1" rowspan="1">Grade 2</td>
<td align="left" colspan="1" rowspan="1">Unrelated</td>
<td align="left" colspan="1" rowspan="1">
<p>Non-</p>
<p>serious</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Week 6</td>
<td align="left" colspan="1" rowspan="1">Cardiac disorders</td>
<td align="left" colspan="1" rowspan="1">Oedema peripheral</td>
<td align="left" colspan="1" rowspan="1">Grade 1</td>
<td align="left" colspan="1" rowspan="1">Unlikely</td>
<td align="left" colspan="1" rowspan="1">
<p>Non-</p>
<p>serious</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Week 9</td>
<td align="left" colspan="1" rowspan="1">
<p>Infections and</p>
<p>infestations</p>
</td>
<td align="left" colspan="1" rowspan="1">Pneumonia</td>
<td align="left" colspan="1" rowspan="1">Grade 5</td>
<td align="left" colspan="1" rowspan="1">Unrelated</td>
<td align="left" colspan="1" rowspan="1">
<p>Results in</p>
<p>death</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Week 9</td>
<td align="left" colspan="1" rowspan="1">
<p>Respiratory, thoracic</p>
<p>and mediastinal</p>
<p>disorders</p>
</td>
<td align="left" colspan="1" rowspan="1">Pulmonary hypertension</td>
<td align="left" colspan="1" rowspan="1">Grade 5</td>
<td align="left" colspan="1" rowspan="1">Unrelated</td>
<td align="left" colspan="1" rowspan="1">
<p>Results in</p>
<p>death</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Week 9</td>
<td align="left" colspan="1" rowspan="1">
<p>Respiratory, thoracic</p>
<p>and mediastinal</p>
<p>disorders</p>
</td>
<td align="left" colspan="1" rowspan="1">Obstructive airways disorder</td>
<td align="left" colspan="1" rowspan="1">Grade 5</td>
<td align="left" colspan="1" rowspan="1">Unrelated</td>
<td align="left" colspan="1" rowspan="1">
<p>Results in</p>
<p>death</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">12</td>
<td align="left" colspan="1" rowspan="1">Aldurazyme</td>
<td align="left" colspan="1" rowspan="1">Week 3</td>
<td align="left" colspan="1" rowspan="1">
<p>Infections and</p>
<p>infestations</p>
</td>
<td align="left" colspan="1" rowspan="1">Nasopharyngitis</td>
<td align="left" colspan="1" rowspan="1">Grade 2</td>
<td align="left" colspan="1" rowspan="1">Unlikely</td>
<td align="left" colspan="1" rowspan="1">
<p>Non-</p>
<p>serious</p>
</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p id="Par30">According to the results, nasopharyngitis was the most commonly reported AE, which was reported by five patients in period 1 and by four patients in period 2. Most of the reported AEs were considered to have ‘unlikely’ and ‘unrelated’ causal relationships with the intervention.</p>
<p id="Par31">Based on the findings, infusion-related reactions, which were probable/likely related to the treatment, were assessed as grade 1 or 2.</p>
<p id="Par32">Two SAEs were reported during the study. One of the patients developed an AE as a result of ingesting the fruit. The patient was hospitalized due to foreign body aspiration and sinusitis at week 13 (period 2, Laronidase (CinnaGen)). Based on the investigator’s opinion, foreign body aspiration and sinusitis had ‘unrelated’ and ‘unlikely’ causal relationships with the treatment, respectively. Another reported SAE resulted in death, and was attributed to the patient’s pre-existing condition. This patient was suffering from significant medical challenges associated with MPS I during the study. Furthermore, the patient experienced airway disorders and peripheral edema. The underlying MPS I conditions progressed to pulmonary hypertension, pneumonia, and obstructive airways disorder, ultimately leading to the patient’s death at week 9 (period 1: Aldurazyme). Based on the investigator’s opinion, this event had an ‘unrelated’ causal relationship to the treatment.</p></section></section><section id="Sec13"><h2 class="pmc_sec_title">Discussion</h2>
<p id="Par33">The results of this study showed that although there were fluctuations in uGAG levels (187.9 CPC unit/g creatinine at baseline, 220.47 CPC unit/g creatinine after Aldurazyme treatment, and 270.02 CPC unit/g creatinine after Laronidase (CinnaGen) treatment), Laronidase (CinnaGen) was able to effectively maintain the uGAG levels stable, as the magnitude of the increase in uGAG levels was not clinically considerable. It is noteworthy that despite the moderate numerical increase in uGAG levels observed between the Aldurazyme and Laronidase (CinnaGen) periods, no corresponding clinical deterioration was noted in patients’ physical function, respiratory capacity, or overall health status. On the contrary, the 6MWT and predicted FVC values showed mild improvement over the same period.</p>
<p id="Par34">The absence of validated thresholds for clinically important changes in uGAG levels for MPS I patients limits the ability to interpret fluctuations strictly based on numerical values. In this context, we considered the trajectory of each patient’s uGAG levels in conjunction with their clinical status.</p>
<p id="Par35">The potential inter-patient variabilities in uGAG levels, could be influenced by factors such as disease activity, prior treatment, genotype, and differences in timing of urine sampling. Another reason for the fluctuations in the uGAG levels in this study could be the presence and development of anti-drug antibodies. As observed in the phase III study of the enzyme, most patients developed antibodies; however, these antibodies did not affect the clinical outcomes despite their impact on uGAG levels<sup><a href="#CR17" class="usa-link" aria-describedby="CR17">17</a></sup>. Antibody measurement was not conducted in the present study, as according to the drug monograph and previous studies, antibodies are developed in almost all patients<sup><a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>–<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a></sup>. Furthermore, given the cross-over study design and the uncertainty surrounding antibody development timing, it would be impossible to determine which product induced the antibody response.</p>
<p id="Par36">In our trial, a formal washout phase was not implemented, as ERT in patients with MPS I—particularly those already stabilized on Aldurazyme—would not have been ethically acceptable. Interrupting treatment could lead to biochemical rebound and clinical deterioration, especially given the progressive nature of the disease. Instead, we ensured that each treatment phase lasted at least 12 weeks, exceeding the known tissue half-life of the enzyme (~ 6 days), which allowed sufficient time for meaningful evaluation of drug-specific effects. The purpose of the initial 12-week Aldurazyme period was to ensure standardized dosing and establish a consistent treatment effects prior to switching.</p>
<p id="Par37">In a case report of an MPS I patient whose ERT was discontinued for two months, a significant increase in uGAG level was observed from 142 mg/g creatinine at the time of ERT discontinuation to 631 mg/g creatinine (more than 4-fold increase) at 6 weeks after ERT discontinuation<sup><a href="#CR20" class="usa-link" aria-describedby="CR20">20</a></sup>. Also, in the phase III and dose optimization studies of Aldurazyme, the greatest decrease in the amount of uGAG was observed in the first three to four weeks of treatment, and after that, fluctuations in the levels of uGAG and sometimes a slight increase in its amount were recorded, which is consistent with the results of this study<sup><a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>,<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a></sup>.</p>
<p id="Par38">In our trial, assessments were performed much longer than the tissue half-lives after switching from Aldurazyme to the biosimilar, which minimizes any residual pharmacological effect. Importantly, we did not observe a rebound increase in uGAG, which would be expected if the biosimilar was ineffective and prior Aldurazyme effects were wearing off. This supports the conclusion that the biosimilar maintained biochemical efficacy. Had our biosimilar been ineffective, we would have expected a surge in uGAG levels after switching from Aldurazyme. The absence of such marked rebound supports therapeutic effect.</p>
<p id="Par39">Although the 6MWT and predicted FVC values showed a numerical increase over the course of the study, these changes were deemed not clinically meaningful. This assessment was based on the absence of consistent, observable improvements in patients’ daily functioning or respiratory status as reported by patients and caregivers. Given the lack of established minimal clinically important difference values for these parameters in MPS I patients, we relied on clinical judgment to interpret the findings. In this context, the modest changes observed were not considered to reflect a meaningful enhancement in functional capacity or pulmonary performance. Thus, it can be concluded that the two medications worked similarly.</p>
<p id="Par40">The enzyme activity assay conducted during the final visits of Aldurazyme and Laronidase (CinnaGen) administration showed no considerable difference between the two medications. Enzyme activity level was undetectable before infusions, then peaked immediately after infusion and gradually declined at 30 and 90 min. The mean enzyme activity levels at various timepoints post-infusion were comparable for both medications.</p>
<p id="Par41">Based on the safety results, it appears that there was no difference in the safety profile between the two study periods. Furthermore, the individual safety results between Laronidase (CinnaGen) and Aldurazyme were comparable, and both medications were well tolerated.</p>
<p id="Par42">There are several limitations in this study. First, it was conducted in a single country with a limited number of patients, focusing on a rare disease. Based on available cases, we set the sample size at 12, making statistical analysis unfeasible. Moreover, we preferred not to include both naïve and non-naïve patients in the study, as the treatment responses differ considerably between these two populations and the study aimed to evaluate the efficacy of a biosimilar Laronidase in maintaining the uGAG levels and clinical efficacy within the ranges provided by Aldurazyme. Including both naïve and previously treated patients would have introduced considerable heterogeneity in treatment response, making interpretation more difficult. Additionally, the majority of eligible patients were already on Aldurazyme as part of routine care, and the availability of truly naïve patients was extremely limited. Another limitation pertains to the endpoints of the study. We do not anticipate dramatic changes or progress in clinical measures as a result of drug usage. Typically, significant changes occur at the start of the treatment, with medications primarily serving to slow disease progression thereafter. Additionally, due to the rare nature of the diseases and the resulting low sample size, performing an equivalency or non-inferiority analysis was not feasible. However, we assessed the ability of Laronidase (CinnaGen) in maintaining the effects provided by Aldurazyme, which was the only way to compare these two medications in the context of this rare disease.</p>
<p id="Par43">Future studies in real-world settings, including treatment-naïve patients, are recommended to assess the effectiveness of the biosimilar product at the initiation of treatment.</p></section><section id="Sec14"><h2 class="pmc_sec_title">Conclusion</h2>
<p id="Par44">According to the results, Laronidase (CinnaGen) successfully maintained the clinical benefits previously established by Aldurazyme. Additionally, the safety profiles of both products were comparable, demonstrating that Laronidase (CinnaGen) is a viable alternative to Aldurazyme for maintaining therapeutic efficacy and safety in MPS I patients.</p>
<p id="Par45">Given its comparable efficacy and safety profile—combined with better accessibility and lower cost—Laronidase (CinnaGen) represents a particularly valuable treatment option for Iranian MPS I patients, addressing critical challenges of affordability and availability in this population.</p></section><section id="Sec15"><h2 class="pmc_sec_title">Supplementary Information</h2>
<p>Below is the link to the electronic supplementary material.</p>
<section class="sm xbox font-sm" id="MOESM1"><div class="media p"><div class="caption">
<a href="/articles/instance/12365282/bin/41598_2025_16351_MOESM1_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 1</a><sup> (93.5KB, pdf) </sup>
</div></div></section></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>A.R., M.A., S.N.A., A.Se., M.Sh., Sh.S., P.E., O.S., A.Sa., and A.J. participated in the study design and coordination, as well as revising the manuscript. H.K. was the head of medical department of Orchid Pharmed Company and supervised the clinical trial conduction, contributed to the writing of the manuscript draft, and analyzed the data. A.R. conducted the study in accordance with the accepted protocol, drafted the manuscript, and decided to submit the manuscript for publication. All authors read and approved the final manuscript and are accountable for all aspects of the work.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>This study was supported by CinnaGen Company.</p></section><section id="notes3"><h2 class="pmc_sec_title">Data availability</h2>
<p>All data generated or analyzed during this study are included in this published article and are available from the corresponding author under reasonable request.</p></section><section id="FPar1"><h2 class="pmc_sec_title">Competing interests</h2>
<p id="Par46">Hamidreza Kafi is the head of the medical department of Orchid Pharmed Company which is in collaboration with CinnaGen company with respect to conducting clinical trials. Araz Sabzvari is a member of CinnaGen medical biotechnology research center. This research center collaborates with universities and researchers all over the world with regards to research and development of medications and health issues. Other authors have no conflict of interest to declare.</p></section><section id="FPar2"><h2 class="pmc_sec_title">Ethics approval</h2>
<p id="Par47">This study was performed in line with the principles of the Declaration of Helsinki and its later amendments, and with Good Clinical Practice guidelines. Approval was granted by the ethics committee of Tehran University of Medical Sciences (IR.TUMS.TIPS.REC.1401.001).</p></section><section id="FPar3"><h2 class="pmc_sec_title">Informed consent</h2>
<p id="Par48">Written informed consent was obtained from all legal guardians of the patients.</p></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn1">
<p><strong>Publisher’s note</strong></p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</div></div></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Hampe, C. S. et al. Mucopolysaccharidosis type I: a review of the natural history and molecular pathology. <em>Cells</em><strong>9</strong>, 1838 (2020).
</cite> [<a href="https://doi.org/10.3390/cells9081838" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7463646/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32764324/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hampe,%20C.%20S.%20et%20al.%20Mucopolysaccharidosis%20type%20I:%20a%20review%20of%20the%20natural%20history%20and%20molecular%20pathology.%20Cells9,%201838%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Nagpal, R. et al. Mucopolysaccharidosis: a broad review. <em>Indian J. Ophthalmol.</em><strong>70</strong>, 2249–2261 (2022).
</cite> [<a href="https://doi.org/10.4103/ijo.IJO_425_22" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9426054/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35791104/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nagpal,%20R.%20et%20al.%20Mucopolysaccharidosis:%20a%20broad%20review.%20Indian%20J.%20Ophthalmol.70,%202249%E2%80%932261%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Kakkis, E. &amp; Marsden, D. Urinary glycosaminoglycans as a potential biomarker for evaluating treatment efficacy in subjects with mucopolysaccharidoses. <em>Mol. Genet. Metab.</em><strong>130</strong>, 7–15 (2020).
</cite> [<a href="https://doi.org/10.1016/j.ymgme.2020.02.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32224020/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kakkis,%20E.%20&amp;%20Marsden,%20D.%20Urinary%20glycosaminoglycans%20as%20a%20potential%20biomarker%20for%20evaluating%20treatment%20efficacy%20in%20subjects%20with%20mucopolysaccharidoses.%20Mol.%20Genet.%20Metab.130,%207%E2%80%9315%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Jameson, E., Jones, S. &amp; Remmington, T. Enzyme replacement therapy with laronidase (Aldurazyme((R))) for treating mucopolysaccharidosis type I. <em>Cochrane Database Syst. Rev.</em><strong>6</strong>, CD009354. 10.1002/14651858.CD009354.pub5 (2019).
</cite> [<a href="https://doi.org/10.1002/14651858.CD009354.pub4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27033167/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jameson,%20E.,%20Jones,%20S.%20&amp;%20Remmington,%20T.%20Enzyme%20replacement%20therapy%20with%20laronidase%20(Aldurazyme((R)))%20for%20treating%20mucopolysaccharidosis%20type%20I.%20Cochrane%20Database%20Syst.%20Rev.6,%20CD009354.%2010.1002/14651858.CD009354.pub5%20(2019)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Coutinho, M. F., Lacerda, L. &amp; Alves, S. Glycosaminoglycan storage disorders: a review. <em>Biochem. Res. Int.</em><strong>2012</strong>, 471325. 10.1155/2012/471325 (2012).</cite> [<a href="https://doi.org/10.1155/2012/471325" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3195295/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22013531/" class="usa-link">PubMed</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Muenzer, J., Wraith, J. E. &amp; Clarke, L. A. International Consensus Panel on, M. &amp; Treatment of Mucopolysaccharidosis, I. Mucopolysaccharidosis I: management and treatment guidelines. <em>Pediatrics</em><strong>123</strong>, 19–29. 10.1542/peds.2008-0416 (2009).</cite> [<a href="https://doi.org/10.1542/peds.2008-0416" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19117856/" class="usa-link">PubMed</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Hampe, C. S. et al. Mucopolysaccharidosis type I: a review of the natural history and molecular pathology. <em>Cells</em><strong>9</strong>, 856. 10.3390/cells9081838 (2020).</cite> [<a href="https://doi.org/10.3390/cells9081838" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7463646/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32764324/" class="usa-link">PubMed</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>LA, C. Mucopolysaccharidosis Type I. <em>Oct 31 [Updated 2024 Apr 11]. In: Adam MP, Feldman J, Mirzaa GM, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025.</em> (2002). <a href="https://www.ncbi.nlm.nih.gov/books/NBK1162/" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/books/NBK1162/</a>.</cite>
</li>
<li id="CR9">
<span class="label">9.</span><cite>Chen, H. H. et al. Enzyme replacement therapy for mucopolysaccharidoses; past, present, and future. <em>J. Hum. Genet.</em><strong>64</strong>, 1153–1171 (2019).
</cite> [<a href="https://doi.org/10.1038/s10038-019-0662-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31455839/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chen,%20H.%20H.%20et%20al.%20Enzyme%20replacement%20therapy%20for%20mucopolysaccharidoses;%20past,%20present,%20and%20future.%20J.%20Hum.%20Genet.64,%201153%E2%80%931171%20(2019)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Fernández-Pereira, C. et al. Therapeutic approaches in lysosomal storage diseases. <em>Biomolecules</em><strong>11</strong>, 1775 (2021).
</cite> [<a href="https://doi.org/10.3390/biom11121775" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8698519/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34944420/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fern%C3%A1ndez-Pereira,%20C.%20et%20al.%20Therapeutic%20approaches%20in%20lysosomal%20storage%20diseases.%20Biomolecules11,%201775%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite><em>European Medicines Agency. Guideline on similar biological medicinal products. CHMP/437/04 Rev 1.</em> (2014). <a href="https://www.sergas.es/Asistencia-sanitaria/Documents/1000/guideline%20on%20similar%20biological%20medicinal%20products%20EMA.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.sergas.es/Asistencia-sanitaria/Documents/1000/guideline%20on%20similar%20biological%20medicinal%20products%20EMA.pdf</a>.</cite>
</li>
<li id="CR12">
<span class="label">12.</span><cite>Lin, S. P. et al. A pilot newborn screening program for mucopolysaccharidosis type I in Taiwan. <em>Orphanet J. Rare Dis.</em><strong>8</strong>, 1–8 (2013).
</cite> [<a href="https://doi.org/10.1186/1750-1172-8-147" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3849552/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24053568/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lin,%20S.%20P.%20et%20al.%20A%20pilot%20newborn%20screening%20program%20for%20mucopolysaccharidosis%20type%20I%20in%20Taiwan.%20Orphanet%20J.%20Rare%20Dis.8,%201%E2%80%938%20(2013)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>Brown, E. G., Wood, L. &amp; Wood, S. The medical dictionary for regulatory activities (MedDRA). <em>Drug Saf.</em><strong>20</strong>, 109–117. 10.2165/00002018-199920020-00002 (1999).
</cite> [<a href="https://doi.org/10.2165/00002018-199920020-00002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10082069/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Brown,%20E.%20G.,%20Wood,%20L.%20&amp;%20Wood,%20S.%20The%20medical%20dictionary%20for%20regulatory%20activities%20(MedDRA).%20Drug%20Saf.20,%20109%E2%80%93117.%2010.2165/00002018-199920020-00002%20(1999)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Freites-Martinez, A., Santana, N., Arias-Santiago, S. &amp; Viera, A. Using the common terminology criteria for adverse events (CTCAE - Version 5.0) to evaluate the severity of adverse events of anticancer therapies. <em>Actas Dermosifiliogr (Engl Ed)</em>. <strong>112</strong>, 90–92. 10.1016/j.ad.2019.05.009 (2021).
</cite> [<a href="https://doi.org/10.1016/j.ad.2019.05.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32891586/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Freites-Martinez,%20A.,%20Santana,%20N.,%20Arias-Santiago,%20S.%20&amp;%20Viera,%20A.%20Using%20the%20common%20terminology%20criteria%20for%20adverse%20events%20(CTCAE%20-%20Version%205.0)%20to%20evaluate%20the%20severity%20of%20adverse%20events%20of%20anticancer%20therapies.%20Actas%20Dermosifiliogr%20(Engl%20Ed).%20112,%2090%E2%80%9392.%2010.1016/j.ad.2019.05.009%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>International <em>Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH Harmonised Tripartite Guideline. Maintenance of the ICH guideline on clinical safety data management: data elements for transmission of individual case safety reports E2B(R2). 2001.</em>.<a href="https://admin.ich.org/sites/default/files/inline-files/E2B_R2_Guideline.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://admin.ich.org/sites/default/files/inline-files/E2B_R2_Guideline.pdf</a>.</cite>
</li>
<li id="CR16">
<span class="label">16.</span><cite><em>Uppsala Monitoring Centre, The use of the WHO-UMC system for standardised case causality assessment. 2018.</em>, <a href="https://who-umc.org/media/164200/who-umc-causality-assessment_new-logo.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://who-umc.org/media/164200/who-umc-causality-assessment_new-logo.pdf</a>.</cite>
</li>
<li id="CR17">
<span class="label">17.</span><cite>Wraith, J. E. et al. Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of Recombinant human α-L-iduronidase (laronidase). <em>J. Pediatr.</em><strong>144</strong>, 581–588 (2004).
</cite> [<a href="https://doi.org/10.1016/j.jpeds.2004.01.046" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15126990/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wraith,%20J.%20E.%20et%20al.%20Enzyme%20replacement%20therapy%20for%20mucopolysaccharidosis%20I:%20a%20randomized,%20double-blinded,%20placebo-controlled,%20multinational%20study%20of%20Recombinant%20human%20%CE%B1-L-iduronidase%20(laronidase).%20J.%20Pediatr.144,%20581%E2%80%93588%20(2004)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Wraith, J. E. et al. Enzyme replacement therapy in patients who have mucopolysaccharidosis I and are younger than 5 years: results of a multinational study of Recombinant human α-L-iduronidase (laronidase). <em>Pediatrics</em><strong>120</strong>, e37–e46 (2007).
</cite> [<a href="https://doi.org/10.1542/peds.2006-2156" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17606547/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wraith,%20J.%20E.%20et%20al.%20Enzyme%20replacement%20therapy%20in%20patients%20who%20have%20mucopolysaccharidosis%20I%20and%20are%20younger%20than%205%20years:%20results%20of%20a%20multinational%20study%20of%20Recombinant%20human%20%CE%B1-L-iduronidase%20(laronidase).%20Pediatrics120,%20e37%E2%80%93e46%20(2007)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>Laronidase : <em>Drug information</em>. <a href="https://www.uptodate.com/contents/laronidase-drug-information?search=laronidase&amp;source=panel_search_result&amp;selectedTitle=1%7E3&amp;usage_type=panel&amp;kp_tab=drug_general&amp;display_rank=1#references" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.uptodate.com/contents/laronidase-drug-information?search=laronidase&amp;source=panel_search_result&amp;selectedTitle=1%7E3&amp;usage_type=panel&amp;kp_tab=drug_general&amp;display_rank=1#references</a>.</cite>
</li>
<li id="CR20">
<span class="label">20.</span><cite>Wegrzyn, G. et al. Rapid deterioration of a patient with mucopolysaccharidosis type I during interruption of enzyme replacement therapy. <em>Am. J. Med. Genet.: A</em>. <strong>143</strong>, 1925 (2007).</cite> [<a href="https://doi.org/10.1002/ajmg.a.31831" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17603800/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wegrzyn,%20G.%20et%20al.%20Rapid%20deterioration%20of%20a%20patient%20with%20mucopolysaccharidosis%20type%20I%20during%20interruption%20of%20enzyme%20replacement%20therapy.%20Am.%20J.%20Med.%20Genet.:%20A.%20143,%201925%20(2007)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Giugliani, R. et al. A dose-optimization trial of laronidase (Aldurazyme®) in patients with mucopolysaccharidosis I. <em>Mol. Genet. Metab.</em><strong>96</strong>, 13–19 (2009).
</cite> [<a href="https://doi.org/10.1016/j.ymgme.2008.10.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19038563/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Giugliani,%20R.%20et%20al.%20A%20dose-optimization%20trial%20of%20laronidase%20(Aldurazyme%C2%AE)%20in%20patients%20with%20mucopolysaccharidosis%20I.%20Mol.%20Genet.%20Metab.96,%2013%E2%80%9319%20(2009)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12365282/bin/41598_2025_16351_MOESM1_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 1</a><sup> (93.5KB, pdf) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>All data generated or analyzed during this study are included in this published article and are available from the corresponding author under reasonable request.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Scientific Reports are provided here courtesy of <strong>Nature Publishing Group</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1038/s41598-025-16351-4"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/41598_2025_Article_16351.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (1.6 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12365282/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12365282/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12365282%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12365282/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12365282/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12365282/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40830667/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12365282/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40830667/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12365282/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12365282/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="jMkdJTSeXLN4RWU0agOvPG04AyYbrGhk0xq3KmpGoRJb21Uji6lcT8M4qDJDGENY">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
